Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen C. Wall is active.

Publication


Featured researches published by Stephen C. Wall.


Annals of the New York Academy of Sciences | 1992

The Platelet Plasma Membrane Serotonin Transporter Catalyzes Exchange between Neurotoxic Amphetamines and Serotonin

Gary Rudnick; Stephen C. Wall

The neurotoxic amphetamines pchloroamphetamine (PCA), fenfluramine, 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) cause release of serotonin from nerve endings followed by degeneration of a subset ofserotone@c terminals. The release phenomenon, which may be responsible for the neurotoxicity, does not require GI*+ when studied in h u , and is blocked by inhibitors of serotonin reuptake, such as fluoxetine and imipramine. Since this serotonin release is poorly understood, we investigated the interaction of PCA with the serotonin transporter of human platelets. Imipramine binding to platelet plasma membrane vesicles is competitively inhibited by each of the neurotoxic amphetamines. The KI values for PCA, fentluramine, MDA and MDMA are 300 nM, 4.4 pM, 7.7 pM, and 14.8 pM, respectively. Other neurotoxins and amphetamines also inhibited imipramine binding. 5,7-dihydmxytryptamine inhibited with a f i . 5 of approximately 2 pM, D-amphetamine inhibited at 49 pM, (+)methamphetamine at 114 pM, but methylphenidate only at 291 pM. This interaction was stereospecific as evidenced by the higher relative K0.s values for DLamphetamine (75 pM) and (+/-)methamphetamine (179) pM. These compounds also inhibit the initial rate of serotonin transport by platelet plasma membrane vesicles. The KI values for competitive inhibition of serotonin transport, however, are lower than the corresponding KI values fbr binding inhibition. KI values for PCA, fenfluramine, MDA and MDMA are 18 nM, 480 nM, 0.82 pM and 0.54 pM, respectively. Inhibition by PCA could be reversed by washing the vesicles free of PCA, indicating that the interaction was reversible. The lower KI for transport inhibition is characteristic of an inhibitor that is itselfa transport substrate. D-Amphetamine and (+)methamphetamine also inhibited transport with K0.s values of 7.4 and 8.7 pM, respectively. The racemic mixtures were less potent. To test the ability of PCA to act as a transport substrate, we took vesicles that had accumulated [3H]serotonin to high levels and diluted them into various media free of [3H]serotonin (FIG. 1). In NaCl medium (control), radioisotope efflux is slow, since the rate of net transport (in + out) is limited by countertransport of K+ (out * in). FIGURE 1 demonstrates the acceleration of net serotonin efflux by external K+ . Serotonin also stimulates [jHIserotonin efflux since self-exchange bypasses the slow coun-


Proceedings of the National Academy of Sciences of the United States of America | 1992

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.

Gary Rudnick; Stephen C. Wall


Journal of Biological Chemistry | 1994

Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence.

Howard H. Gu; Stephen C. Wall; Gary Rudnick


Molecular Pharmacology | 1995

Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.

Stephen C. Wall; Howard H. Gu; Gary Rudnick


Proceedings of the National Academy of Sciences of the United States of America | 1992

The Molecular Mechanism of

Gary Rudnick; Stephen C. Wall


Molecular Pharmacology | 1993

Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.

S Schuldiner; S Steiner-Mordoch; R Yelin; Stephen C. Wall; Gary Rudnick


Biochemistry | 1992

p-Chloroamphetamine induces serotonin release through serotonin transporters

Gary Rudnick; Stephen C. Wall


Molecular Pharmacology | 1993

Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters

Gary Rudnick; Stephen C. Wall


Journal of Biological Chemistry | 1996

Ion Coupling Stoichiometry for the Norepinephrine Transporter in Membrane Vesicles from Stably Transfected Cells

Howard H. Gu; Stephen C. Wall; Gary Rudnick


Biochemistry | 1994

ligand Binding to the Serotonin Transporter: Equilibria, Kinetics, and Ion Dependence

Cynthia J. Humphreys; Stephen C. Wall; Gary Rudnick

Collaboration


Dive into the Stephen C. Wall's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge